TuesdayJan 16, 2024 3:12 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Extensive GLP-1 Study Program

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today unveiled a comprehensive planned applied research program to thoroughly evaluate DehydraTECH for the improved delivery of GLP-1 drugs, designed to support prospective commercial partnering with global pharmaceutical companies. In a recent human pilot study with seven volunteers, Lexaria demonstrated superior pharmacokinetic (“PK”) oral delivery performance of the DehydraTECH-enhanced glucagon-like peptide-1 (“GLP-1”) drug semaglutide, available commercially in the branded product Rybelsus(R). The positive results were sufficient to encourage a much more thorough and expanded investigation. The objective of the new planned studies, as detailed in the announcement, is…

Continue Reading

TuesdayJan 16, 2024 2:48 pm

QualityStocksNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Releases Third-Quarter 2024 Financial Report

FingerMotion (NASDAQ: FNGR), a mobile services and data company, is reporting on its financial results for the third quarter of fiscal 2024, the period ended Nov. 30, 2023. Numbers to note from the report include quarterly revenue of $6.14 million, which includes the company’s SMS & MMS, Telecommunications Products & Services businesses as well as Big Data, totaled $5.26 million, or 46% decrease, compared to Q3 2023; a quarterly decrease in Telecommunications Products & Services business revenue of $4.22 million or 41% compared to Q3 2023; quarterly Big Data revenue of $.01 million compared to $.19 million in Q3 2023;…

Continue Reading

TuesdayJan 16, 2024 2:37 pm

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Business Update, Milestones

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing, development and commercialization of rare cannabinoids and proprietary cannabinoid analogs, today outlined key accomplishments from 2023 and provided key strategic priorities for 2024. “In 2023, we experienced significant progress in both InMed’s pharmaceutical drug development and in BayMedica’s health and wellness initiatives. Our primary accomplishments throughout the year included a number of key milestones, such as the completion of a phase 2 clinical trial and the launch of two new preclinical programs targeting the treatment of Alzheimer’s disease and age-related macular degeneration (‘AMD’),” said Eric A. Adams, InMed president and CEO.…

Continue Reading

TuesdayJan 16, 2024 2:25 pm

QualityStocksNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) Releases CEO Shareholder Message

Renovaro BioSciences (NASDAQ: RENB) (formerly NASDAQ: ENOB), an advanced, preclinical biotechnology firm in cell, gene and immunotherapy focused on solid tumors with short life expectancy, has released a message for its shareholders from CEO Mark Dybul. In the message, Dybul provides an update about key developments the company experienced during 2023, including signing a definitive agreement to combine with the European-based, cutting-edge artificial-intelligence (“AI”) company GEDi Cube; GEDi Cube’s partnership with NVIDIA to expand its multiomic capabilities to multimodal; and consistently achieving “the holy grail of cancer research” in preclinical studies. The company has also scheduled a shareholder meeting on Jan. 25, 2024, to vote…

Continue Reading

TuesdayJan 16, 2024 2:13 pm

QualityStocksNewsBreaks — Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF) (FSE: A0I0) Reports Significant Assay Results at Saskatchewan Project, Upgraded Results in Brazil Project

Appia Rare Earths & Uranium (CSE: API) (OTCQX: APAAF) (FSE: A0I0), a publicly traded Canadian company in the rare earth element and uranium sectors, has announced initial geochemical assay results from its 2023 drilling program; the program was conducted on the Magnet Ridge Zone at Appia’s Alces Lake Project in northern Saskatchewan. According to the announcement, these significant findings “mark a pivotal milestone” in the company's focus and commitment to advance exploration and development initiatives within the prolific Athabasca Basin area. Highlights of the report include returned assays of up to 1.57 wt.% (15,700 ppm) total rare earth oxides (“TREO”), with…

Continue Reading

TuesdayJan 16, 2024 1:12 pm

QualityStocksNewsBreaks — SOBR Safe Inc. (NASDAQ: SOBR) Selected by Navix Health in ‘Significant Milestone’ Collaboration Advancing Digital Health

SOBRSafe (NASDAQ: SOBR), providers of next-generation transdermal alcohol detection solutions, has been selected as an exclusive alcohol data partner by Navix Health, a leading provider of innovative healthcare technologies. Navis Health made the announcement last week. According to the announcement, Navix Health will be integrating SOBRsafe's transdermal detection solutions into its proprietary Navix Hub(TM), which is a fully unified facility and practice management software for behavioral health. “With the integration of the SOBRsafe technology, Navix Hub customers can augment current operations with touch-based alcohol monitoring, the results flowing directly into their client records platform,” the announcement stated. “This collaboration marks…

Continue Reading

FridayJan 12, 2024 3:30 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Looking to Grow Revenue and Commercial Opportunities Through Licensing

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, is committed to providing healthier delivery methods of drugs and other active pharmaceutical ingredients (“APIs”) through its patented drug delivery technology, DehydraTECH(TM). “The company’s efforts have focused on several key segments, including hypertension, diabetes, antivirals, epilepsy, nicotine replacement, and more. This has been an ongoing process since 2016, with positive results achieved from various clinical studies thus far, showing up to 17x brain absorption improvements for oral administration of APIs… Human clinical studies have been conducted since 2018, with more on the way,” a recent article reads. “With…

Continue Reading

FridayJan 12, 2024 3:00 pm

QualityStocksNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Positioned as Go-to Logistics Solution Within USMCA Region

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), a tech company reforming cross-border shipping, recently announced the renewed selection of its Fr8App for Amazon Mexico’s domestic shipping within the USMCA region. “This marks the second year that Amazon Mexico has contracted Fr8Tech, in what the CEO Javier Selgas has attributed to the company’s commitment to meeting customers’ needs and continuously improving its platform. This announcement comes just months after Fr8Tech announced the securing of a Request for Quotation (‘RFQ’) from a leading global pharmaceutical giant, for which it was awarded 33 lanes to transport pharmaceutical goods from the U.S. to both Mexico and…

Continue Reading

FridayJan 12, 2024 1:47 pm

QualityStocksNewsBreaks – Turbo Energy S.A.’s (NASDAQ: TURB) Product Diversification and International Expansion Extend Growth Trajectory

Turbo Energy (NASDAQ: TURB) is unwaveringly committed to developing innovative photovoltaic management solutions tailored for residential, commercial and industrial markets. After a decade dedicated to perfecting SunBox, an innovative AI-powered product tailored for the residential market and designed to manage household energy consumption efficiently and cost-effectively, Turbo Energy appears to show no signs of slowing down. “Building on its existing technical expertise, the company expanded into the EV segment in 2022, launching SunBox with an integrated charger for electric vehicles. What seems to set SunBox apart is its claim to fame as the only EV charger offering three charging modes…

Continue Reading

FridayJan 12, 2024 1:23 pm

QualityStocksNewsBreaks – Mountain Top Properties Inc. (MTPP) Targets Increased Share, High ROI Within Hamptons’ Competitive Real-Estate Market

Mountain Top Properties (OTC: MTPP), a diversified real estate holding company focused on acquiring, marketing and operating assets through its wholly owned affiliates, has sought to capitalize on the evergreen popularity of the Hamptons, which has come to be renowned for its property market’s relative immunity to cyclical trends elsewhere in the nation. “Group subsidiary, Mountain Top Realty Inc. has sought to gain share within the Hampton’s real-estate market through the provision of finished, turnkey properties – a marked contrast to the Hampton’s historical affinity for one-off, customized home sales. Through its Mountain Top Capital Fund I, Mountain Top Realty…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered